Risk of adverse outcomes in inflammatory bowel disease patients infected with SARS-CoV-2: a systematic review and meta-analysis

BACKGROUND: Between people with and without inflammatory bowel disease (IBD), there was no statistically significant difference in the probability of contracting the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). However, the risk of adverse outcomes in IBD patients after virus infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Long, Hu, Kai, Cheng, Cheng, Hu, Quanman, Zhang, Liang, An, Tongyan, Guo, Yongjun, Chen, Shuaiyin, Duan, Guangcai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589854/
https://www.ncbi.nlm.nih.gov/pubmed/36271206
http://dx.doi.org/10.1007/s00384-022-04265-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589854/
https://www.ncbi.nlm.nih.gov/pubmed/36271206
http://dx.doi.org/10.1007/s00384-022-04265-w

Ejemplares similares